Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00006381Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 2000
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of celecoxib in breast cancer, sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoints: Efficacy of celecoxib and trastuzumab and Safety of celecoxib. Started Jun 2000; status: completed.
02
Drugs
celecoxib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00006381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006381.